Estrogen receptor status (ER) determined by immunohistochemistry (IHC) is superior to biochemical ligand-binding (LB) assay for evaluating breast cancer patients

G.M. Clark, Jennet Harvey, C.K. Osborne, D.C. Allred

    Research output: Chapter in Book/Conference paperOther chapter contribution

    Original languageEnglish
    Title of host publicationProgram/Proceedings. American Society of Clinical Oncology. Thirty-Third Annual Meeting. May 17-20, 1997. Denver, CO
    EditorsM.C. Perry
    Place of PublicationDenver, USA
    Publication statusPublished - 1997

    Cite this